Philadelphia, PA, United States of America

Daniel J Rush


Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 229(Granted Patents)


Location History:

  • Philadelphia, PA (US) (2000 - 2003)
  • Morris Township, NJ (US) (2003)

Company Filing History:


Years Active: 2000-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Daniel J. Rush

Introduction

Daniel J. Rush, an accomplished inventor based in Philadelphia, PA, has made significant contributions to the field of pharmaceutical chemistry. With a total of three patents to his name, Daniel's innovations focus on therapeutic compounds that demonstrate potential for enhancing cognitive functions and addressing thrombotic conditions. His work exemplifies the critical intersection of science and creativity in the quest for medical advancements.

Latest Patents

Among his latest patents, Daniel has disclosed innovative formulations such as the "Therapeutic polymorphs of a GABA-A alpha-5 inverse agonist and pamoate formulations of the same," which include various hydrate forms of 3-(5-methylisoxazol-3-yl)-6-(1-methyl-1,2,3-triazol-4-yl)methyloxy-1,2,4-triazolo[3,4-a]phthalazine. These formulations have applications in enhancing cognition and are incorporated into pharmaceutical compositions utilizing pamoate ions for solubilization of neutral molecules.

Additionally, he holds a patent for "Pyrazinone thrombin inhibitors," identifying compounds that effectively inhibit thrombin and combat associated thrombotic occlusions. These include various polymorphic crystalline forms of 3-Fluoro-2-pyridylmethyl-3-(2,2-difluoro-2-(2-pyridyl)ethylamino)-6-chloropyrazin-2-one-1-acetamide, offering promising therapeutic avenues for managing thrombotic disorders.

Career Highlights

Daniel's career has been marked by his tenure at notable companies in the pharmaceutical sector. He has worked at Merck & Company, Inc. and Sandia Corporation, gaining invaluable experience in drug development and innovation. His academic background and professional journey have enabled him to develop patented therapies that align with current medical needs.

Collaborations

Throughout his career, Daniel has collaborated with distinguished professionals, including Darryl Y. Sasaki and C. Jeffrey Brinker. These partnerships have allowed for a diverse exchange of ideas and expertise, enhancing the scope and success of his innovative projects.

Conclusion

Daniel J. Rush stands out as a dedicated inventor whose patents contribute significantly to pharmaceutical advancements. His work not only exemplifies the spirit of innovation but also addresses pressing health challenges through creative and scientifically sound solutions. As he continues to explore new possibilities, the impact of his inventions could resonate across various medical fields, improving patient outcomes and advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…